The regulation of glucagon secretion in the pancreatic α-cell is not well understood. It has been proposed that glucose suppresses glucagon secretion either directly through an intrinsic mechanism, within the α-cell, or indirectly through an extrinsic mechanism. We previously described a mathematical model for isolated pancreatic α-cells and used it to investigate possible intrinsic mechanisms of regulating glucagon secretion. We demonstrated that glucose can suppress glucagon secretion through both ATP-dependent potassium channels (K(ATP)) and a store-operated current (SOC). We now develop an islet model that combines previously published mathematical models of α-and β-cells with a new model of δ-cells and use it to explore the effects of insulin and somatostatin on glucagon secretion. We show that the model can reproduce experimental observations that the inhibitory effect of glucose remains even when paracrine modulators are no longer acting on the α-cell. We demonstrate how paracrine interactions can either synchronize α-and δ-cells to produce pulsatile oscillations in glucagon and somatostatin secretion or fail to do so. The model can also account for the paradoxical observation that glucagon can be out of phase with insulin while α-cell calcium is in phase with insulin. We conclude that both paracrine interactions and the α-cell's intrinsic mechanisms are needed to explain the response of glucagon secretion to glucose.
Introduction
Pancreatic islets consist of three main endocrine cell types that work together to control glucose homeostasis:
α-cells, β-cells, and δ-cells. Pancreatic α-cells release glucagon primarily in response to low blood glucose levels, while pancreatic β-cells secrete insulin when blood glucose is elevated. Pancreatic δ-cells release somatostatin, which is an inhibitor of both insulin and glucagon secretion. Although glucose stimulated insulin secretion is relatively well understood, glucose suppression of glucagon secretion remains a puzzle (1) . Does glucose suppress glucagon secretion directly through intrinsic mechanisms or indirectly through extrinsic mechanisms? This question is part of an ongoing debate in α-cell dynamics. There is evidence that glucose can directly regulate glucagon secretion through ATP-sensitive K + (K(ATP)) (2) channels or a store-operated current (SOC) (3) . However, there is also evidence that islet cells release a variety of factors that can modulate glucagon secretion, such as insulin (4, 5) , Zn + (6, 7), γ-amino butyric acid (GABA) (8) (9) (10) , and somatostatin (11) (12) (13) .
We previously investigated intrinsic mechanisms of regulating glucagon secretion and showed that both K(ATP) channels and SOC are capable of suppressing glucagon secretion, albeit in different ways (14) .
Following the hypothesis of (2), K(ATP) channels suppress secretion in the model by closing when glucose raises the ATP/ADP ratio, as in β-cells. In contrast to β-cells, however, the resulting depolarization reduces spike amplitude by inactivating Na + and Ca 2+ channels. This decreases Ca 2+ influx and reduces glucagon secretion. Following the hypothesis of (3), glucose regulates glucagon secretion in the model through SOC by activating the sarcoendoplasmic reticulum calcium ATPase (SERCA), which pumps Ca 2+ in to the endoplasmic reticulum (ER). When glucose is elevated, the ER fills, turning off SOC, and the consequent hyperpolarization reduces secretion. While the electrical effects of the two mechanisms are opposite, we proposed that SOC and K(ATP) work together to modulate glucagon secretion. For that model of α-cell dy-namics, we neglected the role of paracrine inhibitors of glucagon secretion in order to focus on the intrinsic mechanisms.
In this study, we investigate how insulin and somatostatin can regulate glucagon secretion by combining previously published mathematical models of α- (14) and β-cells (15, 16 ) with a new model of δ-cells to create an islet model: the β-α-δ (BAD) model. We show that the model can reproduce experimental data demonstrating that the inhibitory effect of glucose remains even when paracrine modulators do not act on the α-cell. Based on this finding, we conclude that the role of paracrine interactions in the islet is to modulate the α-cell's intrinsic response to glucose. We also demonstrate how paracrine interactions synchronize α-cells in order to produce pulsatile oscillations in glucagon secretion. We find that the pancreatic β-cells serve as a pacemaker for the islet to drive oscillations in glucagon and somatostatin secretion.
Materials and Methods

Model
The β-α-δ (BAD) model for pancreatic islets contains one representative cell of each type (extended to several α-cells for Fig. 9 ) as well as the interactions between them (Fig. 1) . β-cells are coupled by gap junctions, allowing individual β-cells to synchronize. Therefore, the model β-cell represents all of the β-cells in the islet. However, α-and δ-cells are not coupled by gap junctions, so the α-and δ-cells in the model represent the average behavior of the cells of their respective types, which may all be doing different things.
Pancreatic β-cells secrete by exocytosis of insulin containing granules, which involves a cascade of complex steps such as docking, priming, fusing, and release of insulin. A detailed kinetic model for insulin secretion that includes these processes was developed by Chen et al. (17) . We now add this model of exocytosis to the dual oscillator model for pancreatic β-cells described previously in (15, 16) . The dual oscillator model contains three interacting components, electrical/Ca 2+ , glycolytic, and mitochondrial, that β α δ The α-cell model is taken from (14) . The contribution of K(ATP) channels to glucagon secretion is the same as in (14) . Fig. 2A shows the behavior of the α-cell as a function of the K(ATP) conductance, g K(AT P)a ; the subscript a denotes that this is the conductance in the α-cell. The lines represent constant voltages, and the circles represent the minimum and maximum voltages during spiking. As glucose is increased, g K(AT P)a decreases, and action potentials are produced. Figure 2B reprises from (14) the fundamental feature of α-cell secretion: as g K(AT P)a decreases, glucagon secretion first increases then decreases. The increase is due to the initiation of spiking, whereas the decrease results from reduced spike amplitude, and ultimately loss of spiking, as Na + and Ca 2+ channels inactivate.
The contribution of SOC (not shown) is qualitatively the same as in (14) , but the conductance has been made an order of magnitude smaller; we show below that this is sufficient to account for data on secretion in the absence of K(ATP) channels and when SERCA is blocked. At very low g K(AT P)a the cell settles on a depolarized plateau that does not support secretion.
Finally, we have added a kinetic model of exocytosis, similar to the one used for the β-cells. Inhibition of granule priming due to reduction of cAMP by somatostatin will play a key role in the simulations here.
The δ-cell model is adapted from the α-cell model. We remove the T-type Ca 2+ current, which is absent in mouse δ-cells (18) , and modify the parameters of the remaining ionic currents to shift the dependence of the electrical activity to the left. The dependence of the electrical activity as a function of the δ-cell K(ATP) conductance, g K(AT P)d , is shown in Fig. 2C . As in the α-cell, action potentials are produced when g K(AT P)d is decreased, but there is limited inactivation even when K(ATP) conductance is 0. As a result, somatostatin secretion monotonically increases as g K(AT P)d decreases ( Figure 2D ). Accordingly, somatostatin secretion monotonically increases with glucose. Somatostatin secretion is modeled as a function of microdomain Ca 2+ (Eq. 30 in the Appendix).
Equations and parameters not described here for the three cell types are located in the Appendix.
While each cell type has its own set of electrical, calcium, and secretion equations, we make the simplifying assumption that insulin, glucagon, and somatostatin are secreted into a common, well-mixed space.
The concentrations of insulin (I), glucagon (G), and somatostatin (S) in this compartment are given by the following equations:
where J IS is the rate of insulin secretion, J GS is the rate of glucagon secretion, J SS is the rate of somatostatin glucagon secretion by increasing K(ATP) channel activity (7, 19) ; therefore, the conductance of the α-cell K(ATP) channels (g K(AT P)a ) depends on the concentration of insulin in the common space. The equation for
where EffI a is the effect of insulin on the α-cell andḡ K(AT P)a is the maximal conductance of the K(ATP) channels. EffI a is an increasing function of insulin and is given by the following phenomenological equation
We neglect the recently described additional effect of insulin to lower cAMP (20) , which is subsumed under the effects of somatostatin (see below). The implications of a separate effect of insulin on cAMP will be addressed in the Discussion.
There is also evidence that the β-cell stimulates somatostatin secretion (21) . Moreover, one of the implications of our simulations is that synchrony between insulin and somatostatin is only possible if β-cells stimulate δ-cells. One possible mechanism is a Cl − channel activated by GABA. It has been shown in both rat and human islets that GABA is co-released with insulin in large-dense core granules (22, 23) .
For simplicity, instead of adding equations for GABA, we model the conductance of the GABA current as depending on insulin. I GABA is given by the following equation
where EffI d is the effect of GABA on the δ-cell,ḡ GABA is the maximal conductance of the GABA channel, and v GABA is the reversal potential. Because GABA is co-released with insulin, we assume that GABA is an increasing function of insulin and model EffI d by the following equation
Somatostatin inhibits insulin and glucagon secretion through both G protein-coupled inwardly-rectifying potassium (GIRK) channels and a direct effect on exocytosis (24) (25) (26) (27) . The GIRK current I GIRKx is given by the following equation
where x = a, b for the α-or β-cell respectively, EffS x is the effect of somatostatin,ḡ GIRKx is the maximal conductance of GIRK, and v GIRK is the reversal potential. EffS x is an increasing function of somatostatin and is given by the following equation
Somatostatin inhibits exocytosis both by inhibiting adenylate cyclase, which lowers cAMP levels (28, 29) , and through a pathway independent of cAMP (25, 27 ). In the model, somatostatin inhibits exocytosis by increasing the parameter that governs the rate of depriming of granules, r −2x , where x = a, b for α or β-cell. The equation for r −2x is
Similar results would be obtained if somatostatin were assumed to reduced the rate of priming r 2x . See
Eq. 18 in the Appendix for additional equations governing exocytosis.
Glucagon increases insulin secretion by increasing cAMP levels (29) (30) (31) ). In the model, glucagon increases the parameter that governs the rate of priming granules, r 2,b . The equation for r 2,b is
Similar results would be obtained if glucagon were assumed to increase the rate of resupplying granules, r 3,b (see Eq. 19 in the Appendix).
The differential equations were solved numerically with the variable step size method CVODE implemented in the XPPAUT software package (32) with absolute and relative tolerances 10 −10 .
Results
Effect of Somatostatin on Glucagon Secretion
The role of somatostatin as an inhibitor of glucagon secretion was recently studied in Cheng-Xue et al. in an overall increase in glucagon secretion, but the inhibitory effect of glucose remained. Our model can reproduce the main features of this experiment, as shown in Fig. 3 . In Sst +/+ islets increasing glucose from 1 mM (G1) to 7 mM (G7) decreases glucagon secretion (Fig. 3A , solid curve), while increasing somatostatin and insulin secretion (Fig. 3B,C) . While glucagon secretion is higher in Sst −/− islets, glucose is still able to inhibit secretion (Fig. 3A , dashed curve). Sst −/− islets are modeled by fixingḡ GIRKx to 0 and r −2x to 0.001, removing the effects of somatostatin from the islet. Increasing the glucose concentration decreases the conductance of the K(ATP) channels for all three islet cell types. For this simulation, we assume for simplicity that there are no metabolic oscillations and K(ATP) conductance is constant. Therefore, the change in glucose concentration was modeled as a change inḡ K(AT P)a , g K(AT P)b , and g K(AT P)d , where
, and g K(AT P)a is given by Eq. 4.
Pancreatic α-cells have also been proposed to contain a store-operated current (SOC), which is affected by increasing glucose. SOC is an inward current with a conductance that decreases as ER Ca 2+ increases:
where c er∞ represents C er -dependent activation. In low glucose the ER is relatively depleted because of limited SERCA activation. Increasing glucose activates SERCA and fills the ER, which reduces SOC. This effect of SERCA activity was modeled by a change in the rate of SERCA pump activity, k SERCA (See Eq. 23
in the Appendix). Although somatostatin no longer affects the islets in this simulation, glucose still inhibits glucagon secretion through the closure of K(ATP) channels, the inactivation of a store-operated current (SOC), and insulin.
Although SOC is present in Fig. 3 , it does not play a major role in reducing glucagon secretion, but another experiment in (33) showed that glucose still suppressed glucagon secretionin the absence of K(ATP) channels and somatostatin, using SUR1 −/− islets and pertussis toxin (PTX). Based on this data, it was argued that there exists another mechanism that contributes to glucose suppression of glucagon secretion. We proposed previously (14) that this unknown mechanism is SOC, we now extend this by including paracrine effects. In addition, we found that SOC can be effective even with much smaller conductance (0.015 nS) than was used in (14) .
The first step in modeling SUR1 −/− islets is to remove the K(ATP) current. However, in the absence of any other change, this would result in α-cells that are permanently depolarized. We propose that some other K + conductance must be up-regulated to prevent this from happening. We therefore replaced K(ATP) with a constant K + conductance (0.28 nS). Figure 4A shows that glucose can suppress secretion in the absence of K(ATP) channels both with (solid line) and without (dashed line) the inhibitory effect of somatostatin by deactivating SOC current. Figure 4B shows that only a small SOC curreent is needed: it is sufficient to assume that g SOC is around 0.015 nS in 1 mM glucose and decreases to zero in 7 mM glucose.
The simulations of Figs. 3, 4 suggest that, although somatostatin and insulin have large effects on α-cells, these paracrine factors are not themselves responsible for the glucose sensitivity of glucagon secretion.
We address this further in the Discussion.
Synchronized Hormone Oscillations
We now investigate the role of paracrine effects in hormone oscillations, which have been recorded in high glucose (20 mM) in both isolated islets and the perfused rat pancreas (35) (36) (37) (38) . Insulin and somatostatin oscillate in-phase with each other, but out-of-phase with glucagon. To study this, we now include a glycolytic oscillator in the β-cells to drive insulin oscillations (see Eq. 16 in the Appendix). using this augmented model,but without paracrine interactions, at an elevated level of glucose. In this case insulin secretion is oscillatory (Fig. 5A ), but the secretion of somatostatin and glucagon is flat (Fig. 5B,C) .
Pulsatile insulin secretion depends on two distinct characteristics of β-cells. First, insulin secretion is driven by an intrinsic oscillatory mechanism dependent on glucose metabolism and ion channels (39, 40) .
Second, within an islet, individual β-cells are coupled to neighboring β-cells by gap junctions (41) (42) (43) . This coupling allows the β-cells to secrete in synchrony, and the intrinsic oscillation makes the secretion pulsatile.
Glucagon and somatostatin secretion in the simulation of Fig. 5 are not pulsatile because the α-cell and δ-cell models lack an intrinsic slow oscillator, and can only produce spikes of action potentials. Although, Ca 2+ oscillations have been observed in α-cells (44) (45) (46) (47) , these cells are not coupled by gap junctions like β-cells and are not synchronized. Below (Fig. 9 ), we will come back to the possibility that α-cells contain an intrinsic oscillatory mechanism, but first we examine whether paracrine interactions alone can account for oscillations in glucagon and somatostatin.
In the model, glucagon secretion is influenced both indirectly, through the postulated effects of insulin to open K(ATP) chanels, and directly, by the postulated effect of somatostatin to inhibit exocytosis (Fig. 1) .
Somatostatin is always inhibitory, independent of glucose concentration, but the direction of the insulin effect is ambiguous. That is, the relationship between K(ATP) conductance and glucagon secretion was shown to be a bell-shaped function of the prevailing K(ATP) conductance (48) . The intrinsic response of the isolated α-cell in the model similarly produces a bell-shaped curve as g K(AT P)a is varied, as shown in (14) and repeated here in Fig. 2A . Thus, a glucose-mediated decrease in g K(AT P)a or an insulin-mediated increase in g K(AT P)a can either increase or decrease glucagon secretion, depending on the starting g K(AT P)a level.
In Fig. 6A , we assume that for the given level of glucose the α-cell sits on the right side of the bell-shaped curve (white circle). Then, increasing insulin lowers α-cell Ca 2+ and decreases secretion (black circle, Fig. 6A ). Consequently, both glucagon secretion and α-cell Ca 2+ are anti-phase with insulin (Fig. 6D,E) .
Also, due to the stimulatory effect of the β-cell on somatostatin secretion, insulin and somatostatin oscillate in phase with each other (Fig. 6B,C) .
A recent study, however, reported that α-cell Ca 2+ is in-phase with β-cell Ca 2+ at 20 mM glucose (49) and hence presumably in-phase with insulin. In Fig. 7A , we show that this can happen if the α-cell sits on the left-hand side of the bell (white circle, Fig. 7A ). In this case, insulin increases α-cell Ca 2+
by increasing g K(AT P) . This would normally be expected to increase glucagon secretion (black circle), but somatostatin overcomes the effect of Ca 2+ and is able to suppress glucagon secretion through its direct effect on exocytosis. Therefore, glucagon secretion is anti-phase with insulin ( Fig. 7D) , while Ca 2+ is in-phase (Fig. 7E) . As in Fig. 6 , insulin and somatostatin secretion are in-phase with each other (Fig. 7B,C) .
Although it may seem paradoxical for α-cell Ca 2+ to be out-of-phase with glucagon, the configuration of Fig. 7 avoids another paradox that would afflict Fig. 6 . In that case, g K(AT P) places the α-cell just to the right of the peak of the glucagon secretion curve in high glucose. That means that at low glucose, the physiologically relevant case, the α-cell would sit far to the right of the peak. Then, increases in glucose would increase glucagon secretion, unless counter-balanced by another effect. In low glucose, the paracrine inhibition from somatostatin would be relatively weak and limited in its ability to serve this function.
Oscillations in glucagon are not universally observed. For example, in (50) no oscillations were observed, and no synchrony among α-or δ-cells. Thus, while the structure of islet-cell interactions depicted in Fig. 1 is favorable for coordinated hormone oscillations, it is not sufficient. Fig. 8A -C shows one way that oscillations can fail to occur. If turnover of hormones in the interstitial space is too rapid, the concentration will not build up and dissipate slowly as insulin rises and falls. Another way oscillations could fail to appear is if the β-cells exhibit fast, rather than slow, electrical oscillations ( Fig. 8D-F) . In this case, insulin secretion does not exhibit slow oscillations, so glucagon and somatostatin cannot oscillate. 
Intrinsic Glucagon Pulsatility
As stated earlier, there is some evidence that α-cells may contain an intrinsic glycolytic oscillator (44, 45, 51) . However α-cells are extremely heterogeneous (46, 47, 52) and not coupled by gap junctions like β-cells. We propose that paracrine interactions are needed to synchronize glucagon oscillations even if some or all of the α-cells are intrinsically oscillatory. To test this hypothesis, we extend the model to include five α-cells in addition to the one representative β-cell and one representative δ-cell. The equations for the glycolytic oscillator from (15) were added to the α-cell model (see Eq. 16 in the Appendix). Heterogeneity was incorporated by giving each cell a different value for the parameter J GK , which is the rate of the enzyme glucokinase, and κ, which controls the speed of the glycolytic oscillations; many other parameters could have been used for this illustration. Figure 9A shows the glucagon secretion from the five individual α-cells without the inhibitory effects of insulin or somatostatin. The lack of paracrine interactions was modeled by fixing the conductance of the GIRK and K(ATP) channels and the rate of depriming of granules in the α cells. Three of the α-cells are oscillating, while two are spiking but not undergoing slow oscillations. We include both oscillating and non-oscillating α-cells since it is likely that only a subset of individual α-cells contain oscillations in secretion. The total glucagon secretion from the islet is nearly static (Fig. 9B) , and would be flatter still if more cells were included. However, if we run the same simulation and include the paracrine effects, glucagon secretion becomes pulsatile. In contrast to Fig. 9A, Fig. 9C shows that each individual cell is secreting in an oscillatory fashion and this secretion is synchronized. Since the individual α-cells are now synchronized, the total glucagon secretion is pulsatile (Fig. 9D) . This indicates that another role of paracrine effects is to tame the heterogeneity of α-cells.
Discussion
This study continues the investigation begun in (14) on the roles of intrinsic and paracrine factors in the regulation of glucagon secretion. In the first paper, we showed that two intrinsic mechanisms, K(ATP) channels and SOC channels, could each account for the reduction of glucagon secretion by glucose. In the current study, we have added models for β-and δ-cells in order to investigate paracrine effects in intact pancreatic islets.
We have shown that this β-α-δ (BAD) model can account for experiments in which the effects of somatostatin are absent due to genetic knockout (Fig. 3) or pre-treatment with pertussis toxin (Fig. 4) . In the latter case, K(ATP) channels were also absent (due to genetic knockout), but responsiveness to glucose remained. To the extent that insulin acts by modulating K(ATP) channels, this simulation also demonstrates that glucose can inhibit glucagon secretion independently of insulin secretion. The model shows that the residual glucose sensitivity could be accounted for by the effect of glucose to fill the ER and reduce SOC current.However, recent evidence suggests that insulin may act independently of K(ATP) channels, by reducing cAMP (20) , so SOC may not be solely responsible for the decrease in secretion in the experiments corresponding to Fig. 4 .
The model shows that SOC can effect glucagon secretion even when the conductance is rather small, much smaller than we previously used in (14) .Thus, although there is no direct electrophysical evidence for the existence of SOC current in α-cells, it is possible that it would be difficult to detect experimentally unless other factors, such as somatostatin and K(ATP) channels, are absent or non-functional.
Another channel issue highlighted by Fig. 4 is that some other K + channel likely compensates for the loss of K(ATP) channels. Two possible candidates are TASK-1 (53) and GIRK (54) . Similarly, it is not clear what mechanisms mediate the increase by glucose of somatostatin secretion in δ cells when K(ATP) is knocked-out. It has been suggested that calcium-induced calcium release increases somatostatin secretion provided K(ATP) conductance is reduced sufficiently (34) . In the absence of detailed information about the pathway, we have simply assumed that secretion is amplified when glucose rises.
Our primary focus has been to demonstrate how islets produce pulses of insulin and somatostatin secretion in antisynchrony with those of glucagon. The relevant experiments were carried out at high glucose (20 mM), where we assume SOC is negligible.
Within an islet, β-cells are electrically coupled to their neighbors through gap junctions (41) (42) (43) . This coupling allows the β-cells to secrete in synchrony, generating pulses of insulin secretion (Fig. 5) . On the other hand, α-and δ-cells are not coupled through gap junctions, but we have shown that β-cells can synchronize and drive pulses of glucagon and somatostatin secretion.
For somatostatin to oscillate synchronously with insulin, β-cells must stimulate somatostatin secretion.
In the model, this stimulation comes from GABA, which is co-secreted with insulin (22, 23) and modeled simply as proportional to insulin secretion. Other possible mechanisms include ATP (55) and urocortin3 (56) or any other paracrine factor that oscillates in synchrony with insulin. In the absence of such a mechanism, somatostatin secretion is static (Fig. 5B) , since we assume that individual δ-cells produce spikes of electrical activity but no slow oscillations (some may (44) , but in the absence of synchrony will not produce isletwide pulsatility). However, somatostatin secretion oscillates in synchrony with insulin when the δ-cell is stimulated by the β-cell (Figs. 6B,C& 7B,C) . Thus, β-cells can drive pulses of somatostatin secretion in sufficiently high glucose.
Like somatostatin, glucagon secretion is expected to be static when uncoupled from paracrine effects (Fig. 5C) . We have shown that oscillations in glucagon secretion can be driven by the β-cell, but the δ-cell is needed to guarantee that these oscillations are out of phase with insulin. Under the assumption that insulin secretion modulates K(ATP) channels, its effect on the α-cell can change depending on the K(ATP) conductance in the absence of modulation by insulin. If the K(ATP) conductance is near or to the right of the peak of the bell-shaped curve, as in Fig. 6A , then increasing insulin would reduce secretion. Therefore, inhibition from insulin is all that is necessary to produce antisynchrous oscillations in glucagon secretion (Fig. 6D) . However, if the α-cell K(ATP) conductance is far to the left of the peak, as in Fig. 7A , then increasing insulin would increase secretion. In this case, the inhibitory effect of somatostatin can overcome the rise in Ca 2+ produced by the effect of insulin in order to produce anti-synchronous oscillations in glucagon (Fig. 7D) . Again, insulin could also contribute by reducing cAMP (20) . However, oscillations in α-cell Ca 2+ would be out of phase with glucagon secretion (Fig. 7E) . Although this seems paradoxical, recall that the observations were made in high glucose; the configuration of Fig. 7 is more likely than that of If α-cells are able to oscillate due to intrinsic mechanisms, glucagon secretion would still be static when uncoupled from paracrine interactions (Fig. 9B) . Since α cells are not coupled by gap-junctions like β cells, some other mechanism must exist to synchronize glucagon secretion in order for islets to produce pulses of secretion. We have shown that paracrine effects are sufficient to synchronize glucagon oscillations (Fig. 9D) .
Anti-phase oscillations have been seen in vitro in high glucose levels (20 mM) (35) (36) (37) (38) and in vivo (57) (58) (59) . However the purpose of these asynchronous oscillations is unclear. Perhaps having these oscillations helps keep glucose levels in the appropriate range. It is well known that pulsatile insulin secretion helps the liver function more efficiently. More information is needed about the benefit of pulsatile glucagon secretion.
See (60) Two recent studies have shown, however, that whereas in some α cells cytosolic Ca 2+ decreased with glucose, the majority increased Ca 2+ (61, 62) . We propose that insulin and/or somatostatin could help suppress α cells that inappropriately secrete at high glucose. However, a full exploration of heterogeneity requires a model with hundreds of α-cells to generate distributions of parameters and outcomes. This is more readily done with a simplified model. Results with such a model (Watts and Sherman, manuscript in preparation) provide additional insight into the potent effects of paracrine factors. For example, in our previous model (14) , the J-shaped secretion dose-response curve observed experimentally (63-65) was obtained by combining the effects of SOC and K(ATP). The simplified model indicates that paracrine effects can offer an alternative explanation for this.
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Appendix
The β-α-δ (BAD) model combines the dual oscillator model (DOM) for β-cells, our recent α-cell model, a new model for δ-cells, and the interactions between them. Since a complete mathematical description of the DOM and α-cell model has been published previously, only the key elements of the model will be described here. The equations for the interactions between the cells can be found in the main text and the parameters can be found in Table 3 .
β-cell Model
The DOM consists of three interacting compartments: Electrical/Calcium, Glycolytic, and Mitochondrial 
and the calcium equations for the cell are After entering the cell, glucose is metabolized in glycolysis. It is phosphorylated to glucose-6-phosphate (G6P) by glucokinase (GK), isomerized to fructose-6-phosphate (F6P), then phosphorylated a second time to fructose-1,6-bisphosphate (FBP) by phosphofructokinase-1 (PFK-1), the key enzyme that controls glycolytic oscillations. F6P is assumed to be in equilibrium with G6P; therefore, the equations for the glycolytic
where J PFK and J GPDH are the PFK and GPDH reaction rates and J GK is the glucokinase rate, which is That rate satisfies
We added a kinetic model for granule exocytosis to the DOM in order to model insulin secretion from the β-cell. The kinetic model was taken from Chen et al. (17) . The exocytosis cascade describes the interaction between the insulin containing granules and the plasma membrane inside the β-cell and is divided into seven steps. It is assumed that a granule has to dock to the membrane from a reserve pool, be primed, and move to the microdomain of an L-type Ca 2+ channel before it can bind with Ca 2+ and fuse with the cell membrane.
The number of granules in pool i is given by the following equations:
States 1-6 contain vesicles in the docked and primed states, state F is the number of granules in the fused state, and state R is the number of granules ready to be released. The resupply rate (r 3b ) is assumed to be modulated through an amplifying signal generated from glucose metabolism or other cellular reactions. Here the amplifying signal comes from the mitochondrial compartment. Specifically, the variable J O which is the oxygen consumption at the final stage of the electron transport chain, during which NADH is converted to NAD + . We use this variable because mitochondrial metabolism has been shown to be important for amplification of insulin secretion (66) . The equation for the resupply rate is:
In order to add exocytosis to the DOM, microdomain calcium was modified by the following equation:
This function scales the Ca 2+ in the microdomain to be more in-line with the microdomain Ca 2+ concentrations used in (17) . The rate of insulin secretion J IS is given by the following equation:
Parameters which have been changed from (15) (16) (17) can be found in Table 1 .
α-cell Model
Unlike the β-cell model, the α-cell model (14) 
where J T,a , J L,a , and J N,a are molar Ca 2+ influx through open T-, L-, and N-type Ca 2+ channels.
The kinetic model for granule exocytosis was added to the α-cell model as a replacement for the glucagon secretion equations. This change was necessary to model somatostatin's effect on exocytosis.
The equations are the same as the β-cell equations (see Eq. 18 above) with the exception that we do not include a mitochondrial compartment and assume that the resupply rate (r 3,a ) depends only on calcium: 
The rate of glucagon secretion is:
In order to test the effects of heterogeneity on glucagon oscillations ( 
where γ is given by the following equation: (27) ADP is affected by cytosolic Ca 2+ and glycolysis. The Ca 2+ effect is through the factor (1 − c a /0.45), while input from glycolysis is incorporated through γ. 
and the calcium equations for the cell are 
We modeled somatostatin secretion as depending on Ca 2+ in the microdomains surrounding P/Q type Ca 2+ channels since these channels have been linked to somatostatin secretion (67) . The rate of secretion is expressed as
following the formulation in Pedersen and Sherman (68) . For Fig. 4 , we assume that somatostatin secretion responds to glucose via a K(ATP)-independent amplifying factor. In this case, the secretion equation 
where Amp = 1 in 1 G and 2 in 7 G. Table 2 lists the parameter values which differ from the α-cell model.
